name | description |
---|---|
PK_1cmt | One compartment PK model with linear clearance |
PK_1cmt_des | One compartment PK model with linear clearance using differential equations |
PK_2cmt | Two compartment PK model with linear clearance |
PK_2cmt_des | Two compartment PK model with linear clearance using differential equations |
PK_2cmt_no_depot | Two compartment PK model with linear clearance using differential equations |
PK_2cmt_tdcl_des | Two compartment PK model with time-dependent clearance using differential equations (structured like nivolumab PK model) |
PK_3cmt | Three compartment PK model with linear clearance |
PK_3cmt_des | Three compartment PK model with linear clearance using differential equations |
indirect_0cpt_transitEx | Two compartment PK model with Michealis-Menten clearance using differential equations |
PK_2cmt_mAb_Davda_2014 | Two compartment PK model with linear clearance for average monoclonal antibodies (Davda 2014) |
CarlssonPetri_2021_liraglutide | Liraglutide PK model in adolescents (Carlsson Petri 2021) |
Kovalenko_2020_dupilumab | Dupilumab PK model (Kovalenko 2020) |
Soehoel_2022_tralokinumab | Tralokinumab PK model (Soehoel 2022) |
Zhu_2017_lebrikizumab | Lebrikizumab PK model (Zhu 2017) |
oncology_sdm_lobo_2002 | Signal transduction model for delayed concentration effects on cancer cell growth |
oncology_xenograft_simeoni_2004 | Oncology tumor growth model in xenograft models |